AFP is a critical component of the quadruple screen test, which is a maternal blood screening test conducted during the second trimester of pregnancy. It helps to assess the risk of certain fetal conditions such as neural tube defects (e.g., spina bifida) and chromosomal abnormalities like Down syndrome. Abnormal levels of AFP in maternal blood can indicate a need for further diagnostic testing.
